« Back to Farmacia Journal 6/2017
OFF-LABEL USE OF BEVACIZUMAB IN ONCOLOGY PATIENTS. INFLUENCE ON EFFECTIVENESS, SECURITY AND COSTS
JUAN FRANCISCO MARIN POZO 1*, JUAN MANUEL DUARTE PEREZ 2, PEDRO SANCHEZ ROVIRA 3
1.Board Certified Oncology Pharmacist (BCOP), Hospital Pharmacy Department, Complejo Hospitalario de Jaén, Spain
2.Faculty of Pharmacy, University of Granada, Spain
3.Medical Oncology Specialist, Medical Oncology Department, Complejo Hospitalario de Jaén, Spain